RSCI
Price
$0.07
Change
-$0.10 (-58.82%)
Updated
May 13 closing price
Capitalization
14.29M
TKPHF
Price
$28.56
Change
+$1.06 (+3.85%)
Updated
Aug 7 closing price
Capitalization
45.86B
Interact to see
Advertisement

RSCI vs TKPHF

Header iconRSCI vs TKPHF Comparison
Open Charts RSCI vs TKPHFBanner chart's image
Redwood Scientific Technologies
Price$0.07
Change-$0.10 (-58.82%)
Volume$13.39K
Capitalization14.29M
Takeda Pharmaceutical
Price$28.56
Change+$1.06 (+3.85%)
Volume$250.1K
Capitalization45.86B
RSCI vs TKPHF Comparison Chart in %
Loading...
RSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RSCI vs. TKPHF commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSCI is a Hold and TKPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (RSCI: $0.07 vs. TKPHF: $28.56)
Brand notoriety: RSCI and TKPHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: RSCI: 100% vs. TKPHF: 140%
Market capitalization -- RSCI: $14.29M vs. TKPHF: $45.62B
RSCI [@Pharmaceuticals: Generic] is valued at $14.29M. TKPHF’s [@Pharmaceuticals: Generic] market capitalization is $45.62B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $66.04B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RSCI’s FA Score shows that 0 FA rating(s) are green whileTKPHF’s FA Score has 1 green FA rating(s).

  • RSCI’s FA Score: 0 green, 5 red.
  • TKPHF’s FA Score: 1 green, 4 red.
According to our system of comparison, TKPHF is a better buy in the long-term than RSCI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RSCI’s TA Score shows that 2 TA indicator(s) are bullish while TKPHF’s TA Score has 6 bullish TA indicator(s).

  • RSCI’s TA Score: 2 bullish, 0 bearish.
  • TKPHF’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RSCI is a better buy in the short-term than TKPHF.

Price Growth

RSCI (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while TKPHF (@Pharmaceuticals: Generic) price change was +3.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.48%. For the same industry, the average monthly price growth was +8.38%, and the average quarterly price growth was +79.14%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.48% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKPHF($45.9B) has a higher market cap than RSCI($14.3M). TKPHF YTD gains are higher at: 6.776 vs. RSCI (-32.432).
RSCITKPHFRSCI / TKPHF
Capitalization14.3M45.9B0%
EBITDAN/A1.13T-
Gain YTD-32.4326.776-479%
P/E RatioN/A49.17-
RevenueN/A4.48T-
Total CashN/A419B-
Total DebtN/A4.51T-
FUNDAMENTALS RATINGS
RSCI vs TKPHF: Fundamental Ratings
RSCI
TKPHF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10089
PRICE GROWTH RATING
1..100
9159
P/E GROWTH RATING
1..100
10037
SEASONALITY SCORE
1..100
750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TKPHF's Valuation (5) in the null industry is somewhat better than the same rating for RSCI (38). This means that TKPHF’s stock grew somewhat faster than RSCI’s over the last 12 months.

TKPHF's Profit vs Risk Rating (100) in the null industry is in the same range as RSCI (100). This means that TKPHF’s stock grew similarly to RSCI’s over the last 12 months.

TKPHF's SMR Rating (89) in the null industry is in the same range as RSCI (100). This means that TKPHF’s stock grew similarly to RSCI’s over the last 12 months.

TKPHF's Price Growth Rating (59) in the null industry is in the same range as RSCI (91). This means that TKPHF’s stock grew similarly to RSCI’s over the last 12 months.

TKPHF's P/E Growth Rating (37) in the null industry is somewhat better than the same rating for RSCI (100). This means that TKPHF’s stock grew somewhat faster than RSCI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSCITKPHF
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
47%
Stochastic
ODDS (%)
N/A
Bearish Trend 4 days ago
62%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
42%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
42%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
56%
Bearish Trend 4 days ago
46%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
39%
Declines
ODDS (%)
N/A
Bearish Trend 15 days ago
42%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
61%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
43%
View a ticker or compare two or three
Interact to see
Advertisement
RSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUST1.370.03
+2.49%
Austin Gold Corp
VRSK265.040.52
+0.20%
Verisk Analytics
HSTM25.980.04
+0.15%
HealthStream
MEIP5.10N/A
N/A
MEI Pharma
TNL58.88-0.21
-0.36%
Travel + Leisure Co

RSCI and

Correlation & Price change

A.I.dvisor tells us that RSCI and TAK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSCI and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSCI
1D Price
Change %
RSCI100%
N/A
TAK - RSCI
24%
Poorly correlated
+0.56%
ETST - RSCI
22%
Poorly correlated
+5.69%
TEVJF - RSCI
5%
Poorly correlated
-19.55%
ROMJF - RSCI
5%
Poorly correlated
+4.23%
PHCUF - RSCI
3%
Poorly correlated
N/A
More

TKPHF and

Correlation & Price change

A.I.dvisor tells us that TKPHF and TCNNF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TCNNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKPHF
1D Price
Change %
TKPHF100%
N/A
TCNNF - TKPHF
14%
Poorly correlated
+5.52%
VTRS - TKPHF
11%
Poorly correlated
+3.30%
SGIOY - TKPHF
9%
Poorly correlated
+1.11%
SFOSF - TKPHF
7%
Poorly correlated
N/A
RSCI - TKPHF
2%
Poorly correlated
N/A
More